Deciphera Pharmaceuticals Stock (NASDAQ:DCPH), Quotes and News Summary

Q: What sector and industry does Deciphera Pharmaceuticals (DCPH) operate in?

Deciphera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Deciphera Pharmaceuticals Stock (NASDAQ: DCPH) stock price, news, charts, stock research, profile.

Open	$14.670
Close	$14.230
Volume / Avg.	764.426K / 538.905K
Day Range	14.190 - 14.910
52 Wk Range	9.900 - 17.730
Market Cap	$1.150B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	9.99%
Days to Cover	12.21

Recent News

Deciphera Pharmaceuticals' Investigational Drug Shows Encouraging Response Rates In Rare Type Of Cancer

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) announced top-line results from the MOTION Phase 3 study of vimseltinib in patients with Tenosynovial Giant Cell Tumor (TGCT)

Vandana Singh

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst

Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Nov 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Deciphera Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inh...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Deciphera Pharmaceuticals (DCPH) stock?

You can purchase shares of Deciphera Pharmaceuticals (NASDAQ: DCPH) through any online brokerage.

View our list of the best stock brokerages.

Who are Deciphera Pharmaceuticals's (DCPH) competitors?

Other companies in Deciphera Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the target price for Deciphera Pharmaceuticals (DCPH) stock?

The latest price target for Deciphera Pharmaceuticals (NASDAQ: DCPH) was reported by JP Morgan on Wednesday, March 20, 2024. The analyst firm set a price target for 16.00 expecting DCPH to rise to within 12 months (a possible 12.44% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Deciphera Pharmaceuticals (DCPH)?

The stock price for Deciphera Pharmaceuticals (NASDAQ: DCPH) is $14.23 last updated April 18, 2024 at 4:00 PM EDT.

Does Deciphera Pharmaceuticals (DCPH) pay a dividend?

There are no upcoming dividends for Deciphera Pharmaceuticals.

When is Deciphera Pharmaceuticals (NASDAQ:DCPH) reporting earnings?

Deciphera Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Is Deciphera Pharmaceuticals (DCPH) going to split?

There is no upcoming split for Deciphera Pharmaceuticals.

What sector and industry does Deciphera Pharmaceuticals (DCPH) operate in?

Deciphera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-